Repligen | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Agilent USD 376M 32M 2025-01
Align Technology USD 144.15M 18.15M 2024-12
Bio Techne USD 47.42M 7.43M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Bruker USD 64.1M 4M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Danaher USD 1.28B 142M 2025-03
Dentsply International USD -509000000 47M 2024-12
Exact Sciences USD -876351000 836.95M 2024-12
General Electric USD 1.74B 345M 2025-03
Henry Schein USD 155M 2M 2024-12
Illumina USD 175M 566M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
Mettler Toledo International USD 314.55M 295.95M 2024-12
Myriad Genetics USD -39000000 19M 2024-12
Patterson Companies USD 45.44M 7.8M 2025-01
Pfizer USD -409000000 5.57B 2024-12
Repligen USD -36501000 28.9M 2024-12
Revvity USD 118.75M 20.6M 2024-12
Standard Biotools USD -32817000 1.1M 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12
Waters USD 292.26M 81.13M 2024-12
West Pharmaceutical Services USD 159.6M 1.7M 2024-12



Repligen Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.